These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9481702)

  • 1. Endothelin receptor antagonists: which are the therapeutic perspectives in renal diseases?
    Benigni A; Remuzzi G
    Nephrol Dial Transplant; 1998 Jan; 13(1):5-7. PubMed ID: 9481702
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic potential of endothelin receptor antagonism in kidney disease.
    Czopek A; Moorhouse R; Webb DJ; Dhaun N
    Am J Physiol Regul Integr Comp Physiol; 2016 Mar; 310(5):R388-97. PubMed ID: 26702154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelin antagonists in renal disease.
    Hendry BM; James AF
    Lancet; 1997 Aug; 350(9075):381-2. PubMed ID: 9259650
    [No Abstract]   [Full Text] [Related]  

  • 4. Endothelin in renal pathophysiology: from experimental to therapeutic application.
    Rabelink TJ; Kaasjager KA; Stroes ES; Koomans HA
    Kidney Int; 1996 Dec; 50(6):1827-33. PubMed ID: 8943463
    [No Abstract]   [Full Text] [Related]  

  • 5. The renoprotective potential of endothelin receptor antagonists.
    Knoll T; Schaub M; Birck R; Braun C; Juenemann KP; Rohmeiss P
    Expert Opin Investig Drugs; 2000 May; 9(5):1041-52. PubMed ID: 11060726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targets for endothelin in the diseased kidney: clues for therapeutic intervention.
    Rohmeiss P; Birck R; Braun C; Kirchengast M; van der Woude FJ
    Exp Nephrol; 1999; 7(1):1-10. PubMed ID: 9892807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelin, kidney disease, and hypertension.
    Speed JS; Pollock DM
    Hypertension; 2013 Jun; 61(6):1142-5. PubMed ID: 23608655
    [No Abstract]   [Full Text] [Related]  

  • 8. The Twelfth International Conference on Endothelin (ET-12), Cambridge 2011.
    Barton M; Davenport AP
    Life Sci; 2012 Oct; 91(13-14):462-5. PubMed ID: 22842028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelin in hypertension: a role for receptor antagonists?
    Moreau P
    Cardiovasc Res; 1998 Sep; 39(3):534-42. PubMed ID: 9861294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelin receptors, renal effects and blood pressure.
    Boesen EI
    Curr Opin Pharmacol; 2015 Apr; 21():25-34. PubMed ID: 25544397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ETA receptor-mediated responses to endothelin-1 and big endothelin-1 in the rat kidney.
    Pollock DM; Opgenorth TJ
    Br J Pharmacol; 1994 Mar; 111(3):729-32. PubMed ID: 8019752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The endothelin system and endothelin receptor antagonists.
    Jandeleit-Dahm KA; Watson AM
    Curr Opin Nephrol Hypertens; 2012 Jan; 21(1):66-71. PubMed ID: 22123210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blocking of the endothelin system: the development of receptor antagonists.
    Battistini B; Dussault P
    Pulm Pharmacol Ther; 1998; 11(2-3):97-112. PubMed ID: 9918742
    [No Abstract]   [Full Text] [Related]  

  • 14. Novel strategies to retard renal disease progression: combining ACE inhibition with endothelin receptor blocking?
    Benigni A; Remuzzi G
    Nephrol Dial Transplant; 1998 Nov; 13(11):2734-8. PubMed ID: 9829469
    [No Abstract]   [Full Text] [Related]  

  • 15. Endothelin antagonists and resistant hypertension in chronic kidney disease.
    Moore R; Linas S
    Curr Opin Nephrol Hypertens; 2010 Sep; 19(5):432-6. PubMed ID: 20502329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence from receptor antagonists of an important role for ETB receptor-mediated vasoconstrictor effects of endothelin-1 in the rat kidney.
    Wellings RP; Corder R; Warner TD; Cristol JP; Thiemermann C; Vane JR
    Br J Pharmacol; 1994 Feb; 111(2):515-20. PubMed ID: 8004396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelin antagonists in renal disease.
    Benigni A
    Kidney Int; 2000 Apr; 57(4):1778-94. PubMed ID: 10760116
    [No Abstract]   [Full Text] [Related]  

  • 18. Renal actions of endothelin-1 in newborn piglets: dose-effect relation and the effects of receptor antagonist (BQ-123) and cyclooxygenase inhibitor (indomethacin).
    Bhat R; John E; Chari G; Shankararao R; Fornell L; Gulati A; Vidyasagar D
    J Lab Clin Med; 1995 Nov; 126(5):458-69. PubMed ID: 7595031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrasting pharmacological ETB receptor blockade with genetic ETB deficiency in renal responses to big ET-1.
    Pollock DM
    Physiol Genomics; 2001 Jun; 6(1):39-43. PubMed ID: 11395545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Endothelins: possibly a new pharmacological approach in cardiovascular diseases, kidney diseases and oncological disorders].
    Kroodsma JM; Rabelink AJ
    Ned Tijdschr Geneeskd; 1997 Sep; 141(38):1806-10. PubMed ID: 9545734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.